Navigation Links
Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Date:8/28/2007

nhibitors into the company's early-stage pipeline and to support the company's current partnership.

In line with these portfolio decisions, Sunesis is reducing operating expenses primarily in the research and general & administrative areas. As part of the reorganization, the company is eliminating a total of 35 full-time employee positions, and will now have 108 employees. Sunesis expects that this realignment of personnel, operations and programs will reduce annual expenses by more than $10 million below its planned levels for the next several years.

"With the talent, focus and commitment of the Sunesis team, we have the opportunity to generate transforming clinical data in the coming quarters. By proactively undertaking the realignment, we can focus on the execution of our revised operating plan without needing to raise additional funds or entering into a corporate partnership in 2008," said Daniel Swisher, Chief Executive Officer and President of Sunesis. "The workforce reductions we're announcing today are difficult. We are deeply grateful for the dedication and contributions of the employees who will be leaving Sunesis and wish them the very best in all their future endeavors."

The company will be providing severance and career transition assistance to those employees directly affected by the restructuring. As a result of the restructuring plan, Sunesis estimates that it will record a one-time restructuring charge in the third quarter of 2007 of between approximately $1.0-1.2 million for personnel costs and approximately $0.5-0.8 million for facilities-related and other costs. Sunesis estimates that the total amount of the restructuring charge will be between $1.5-2.0 million. The cash portion of this restructuring charge will be approximately $1.0-1.2 million. As of June 30, 2007, Sunesis had cash, cash equivalents and marketable securities of $65.2 million. The company now anticipates that cash used in operating activities in 2007 will be le
'/>"/>

SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Speaker announces business members of IT Task Force
4. Doyle announces technology tax credits for Berbee
5. Doyle announces new energy, global warming policies
6. Doyle announces $80M renewable energy strategy
7. GE announces first installation of Discovery VCT
8. UWM announces winners of RGI awards
9. Third Wave announces two senior management appointments
10. Mirus announces new method for making antibodies
11. Merge announces sofware updates, upcoming acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Decision Resources, one of the world,s ... healthcare issues, finds that, according to responses from ... briakinumab (both interleukin inhibitors) will capture 22 percent ... drug market for moderate to severe psoriasis. Among ... capturing nearly three times as much patient share ...
(Date:12/16/2009)... conducted pursuant to Special Protocol Assessment with ... CITY, Dec. 16 /PRNewswire-FirstCall/ - AEterna Zentaris ... (the "Company"), a global biopharmaceutical company focused ... the initiation, by its partner Keryx Biopharmaceuticals ... 3 registration clinical trial for perifosine (KRX-0401), ...
(Date:12/16/2009)... A has been found to be effectinve in improving yelds of ... ... Nu-Tek BioSciences, LLC. ( www.nu-tekproducts.com ) is meeting the demand for ... by Nutricepts, Inc. (Burnsville, Mn), is a high quality Soy Peptone. ... HSP-A has been found to be especially effective in improving yields ...
(Date:12/15/2009)... Joint BioEnergy Institute (JBEI), one of three Department of ... trusted time-stamping service to protect its valuable intellectual property. ... ... VA (PRWEB) December 15, 2009 -- Surety, LLC ... solutions , today announced that the Joint BioEnergy Institute ...
Breaking Biology Technology:In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 2In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 2AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 4AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 5Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 2Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 3Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 4Joint BioEnergy Institute Selects Surety's AbsoluteProof to Protect the Integrity and Legally Defend the Authenticity of its Scientific Intellectual Property 5
... N.Y. A new technique for growing single-crystal ... enable the development of smaller, more powerful heat ... , Researchers at Rensselaer Polytechnic Institute have discovered ... up of two single crystals using a biomolecular ...
... with,CorVel Corporation,s (Nasdaq: CRVL ) quarterly earnings release, CorVel will,be conducting ... August 5th at 11:30 am Eastern Time., Event: ... Dan Starck, President and CEO ... 11:30 am Eastern Time, Tuesday, August 5th, ...
... 17 Researchers at Fred Hutchinson Cancer,Research Center ... the,National Human Genome Research Institute to better understand ... Hutchinson Center is one of,four U.S. research institutes ... effort., The Hutchinson Center project, led by ...
Other Biology Technology:'Nanosculpture' could enable new types of heat pumps and energy converters 2CorVel Corporation Announces Earnings Release Webcast 2Hutchinson Center Receives $7.6 Million Federal Grant to Study How Genetic Variations Influence Risk of Common Diseases 2Hutchinson Center Receives $7.6 Million Federal Grant to Study How Genetic Variations Influence Risk of Common Diseases 3
(Date:12/16/2009)... 9 BIO-key International, Inc. (OTC ... biometric identification solutions, today announced that SC ... security publications, named BIO-key International the 2009 ... Control sub-category Biometrics. ,, (Logo: ... technology editor, SC Magazine, "Biometric providers have ...
(Date:12/15/2009)... 15 The 2009 Frost & ... is presented to Sagem Securite (Safran Group) ... The award recognises the company,s expertise in ... in offering novel, value-added products to end ... ) ,, "Sagem Securite has been involved ...
(Date:12/15/2009)... the British Society for Research on Ageing (BSRA) to ... for an initial period of three years. ... Biogerontology editorial board and will acquire articles for ... society and provide society members with free electronic access ... Biogerontology offers a platform for research which ...
Breaking Biology News(10 mins):BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 2BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 3Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 2Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 3Frost & Sullivan Recognises Sagem Securite for its Innovative Automated Border Control Systems 4Auroras Milwaukee Hospitals Recognized in US News and World Report 51970 1Auroras Milwaukee Hospitals Recognized in US News and World Report 51970 2VIVIMIND 28TM 29 granted certificate of free sale as food supplement in Italy Premarket notification filed in the U S 51966 1VIVIMIND 28TM 29 granted certificate of free sale as food supplement in Italy Premarket notification filed in the U S 51966 2VIVIMIND 28TM 29 granted certificate of free sale as food supplement in Italy Premarket notification filed in the U S 51966 3Omnicell to Release Second Quarter 2009 Earnings Results on July 23 51961 1Omnicell to Release Second Quarter 2009 Earnings Results on July 23 51961 2
... in culture to mimic the properties of the heart ... the mechanisms that spawn irregular heart rhythms. Studies of ... such as those delivered by defibrillators usually stopped aberrant ... and multiply. , The Duke University and Johns Hopkins ...
... the Food and Drug Administration's clearance of a new ... technology developed at the university. This action signals a ... prosthetic replacements toward regenerative medicine, in which materials help ... , The device consists of a surgical mesh ...
... single gene apparently thwarts a disease-causing invader that creates ... But the same gene provides access to a different ... biologist and his collaborators in Austria and North Carolina ... also triggers a defense against disease. The gene and ...
Other Biology News:Engineered heart tissue offers insights into irregular heartbeats, defibrillator failure 2Engineered heart tissue offers insights into irregular heartbeats, defibrillator failure 3FDA approves first medical device using rutgers biomaterial 2Gene thwarts some pathogens, gives access to others, could save crops 2Gene thwarts some pathogens, gives access to others, could save crops 3
This free-standing laminar flow hood provides a vertical flow of HEPA-filtered air to create a clean processing area. It includes a fluorescent light and motorized sliding shield. Options include wor...
... Orbit LS Low Speed Shaker ... low speed shaker is a high quality, general ... ,Styled after the other models in the ... design with easy-access control panel. Electronic controls are ...
This modular laminar flow hood forces air through a 99.99% efficient HEPA filter to create a clean processing area. Configurations are available with vertical or horizontal flow; options include a wo...
... 3-D Shaker , ,Product Information ... the GyroTwister GX-1000 is extremely efficient, yet ... mixing as well as staining gels, hybridization ... adjustable across a broad range. A nonslip ...
Biology Products: